What are the experiences of people with MS using GLP-1 weight loss drugs?
GLP-1 receptor agonists (like Ozempic/Wegovy) have been a hot topic in the MS community. A small study of 33 people with MS who took GLP-1 drugs for an average of 15 months found some encouraging results.
Here's what the research showed:
- No Show Full Answer
What are the experiences of people with MS using GLP-1 weight loss drugs?
GLP-1 receptor agonists (like Ozempic/Wegovy) have been a hot topic in the MS community. A small study of 33 people with MS who took GLP-1 drugs for an average of 15 months found some encouraging results.
Here's what the research showed:
- No participants had an MS relapse during the study period
- Most were also taking a disease-modifying therapy (DMT) alongside the GLP-1 drug
- The drugs appeared to be generally safe and well-tolerated
- About 1 in 4 people experienced gastrointestinal side effects like nausea, stomach pain, or vomiting
- Only one person stopped taking the medication due to side effects
- Some participants did show new lesions on MRI scans by the end of the study Neurologist Dr. Aaron Boster cautions that GLP-1 drugs aren't a standalone solution. He describes them as a helpful addition to — not a replacement for — healthy lifestyle changes.
His key advice includes:
- Pair any weight-loss medication with an exercise program
- Make meaningful changes to eating habits
- Avoid "yo-yo" weight cycling, as dramatic weight fluctuations can be hard on the heart
- Work closely with a healthcare team to build sustainable habits
There's also early-stage research exploring whether GLP-1 drugs might help protect or rebuild myelin (the nerve coating damaged by MS), but clinical trials haven't been done yet — so that's one to watch for the future!
Always speak with your doctor before starting any new medication to make sure it's the right fit for your specific situation.
July 13
Join
Your Privacy Choices
